APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,623,059 | +403.0% | 226,684 | +1104.6% | 0.03% | +383.3% |
| Q2 2023 | $1,714,320 | +429.3% | 18,818 | +283.3% | 0.01% | +500.0% |
| Q1 2023 | $323,864 | -87.7% | 4,910 | -90.3% | 0.00% | -83.3% |
| Q4 2022 | $2,628,057 | +125.0% | 50,823 | +96.8% | 0.01% | +200.0% |
| Q2 2022 | $1,168,000 | -58.6% | 25,823 | -53.5% | 0.00% | -33.3% |
| Q1 2022 | $2,822,000 | +65.7% | 55,546 | +54.2% | 0.00% | +200.0% |
| Q4 2021 | $1,703,000 | -51.1% | 36,021 | -65.9% | 0.00% | -75.0% |
| Q3 2021 | $3,486,000 | +7014.3% | 105,752 | +6391.8% | 0.00% | – |
| Q3 2020 | $49,000 | +2350.0% | 1,629 | +1529.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |